|
Company Name |
SEIKAGAKU CORPORATION |
|---|
|
President |
Ken Mizutani |
|---|
|
Establishment |
June 2, 1947 |
|---|
|
Business activities |
Manufacturing and sales of pharmaceuticals and medical devices specifically related to glycoconjugates. |
|---|
|
Stock Exchange Listing |
Tokyo Stock Exchange, Prime Market |
|---|
|
Number of Employees |
988(Consolidated) |
|---|
|
Paid-in Capital |
¥3,840 million |
|---|
|
Net Sales |
¥36,213 million |
|---|
|
Authorized Outstanding Shares |
56,814,093 |
|---|
|
Number of Shareholders |
10,878 |
|---|
(As of March 31, 2024)
Marunouchi Center Building 10fl.
6-1, Marunouchi 1-chome, Chiyoda-ku
Tokyo 100-0005, Japan
Tel: (81) 3-5220-8950
Fax: (81) 3-5220-8951
1253, Tateno 3-chome, Higashiyamato-shi
Tokyo 207-0021, Japan
Tel: (81) 42-563-5811
Fax: (81) 42-563-5848
3-1, Kurihama 9-chome, Yokosuka-shi
Kanagawa 239-0831, Japan
Tel: (81) 46-835-3311
Fax: (81) 46-834-1918
258-5, Aza-Matsukubo, Oaza-Akahama
Takahagi-shi, Ibaraki 318-0001, Japan
Tel: (81) 293-23-1181
Fax: (81) 293-23-7542
124 Bernard E.Saint Jean Drive, East Falmouth MA 02536, U.S.A
Tel: (1)508-540-3444
Fax: (1)508-540-8680
| Paid-in Capital: | $2,080 |
| Business: | Manufacturing and sales of endotoxin-detecting reagents |
349 Wildcat Rd. Toronto, ON M3J 2S3,
CANADA
Tel: (1)416-661-2102 / (1)800-567-5060
| Paid-in Capital: | 49,800 (units: CAD 1,000) |
| Business: | CDMO (Manufacturing of chemosynthesis products and API, API process development and Manufacturing of sterile dosage forms) |
